Intrathecal Infusion of Autologous Adipose-Derived Regenerative Cells in Autoimmune Refractory Epilepsy: Evaluation of Safety and Efficacy

Figure 5

Quantitative analysis of cytokine and chemokine level in CSF during ADRC treatment. Comparison of Angiogenin, IL-10, CXCL10/SDF-1α, Osteopontin, and TNF-α concentration, determined by the Luminex multiplex cytokine analysis method, in CSF, before and after ADRC application (black graph bars/t1—before ADRC application, light grey bars/t2—3 months after 1^st ADRC application, medium grey bars/t3—3 months after 2^nd ADRC application, dark grey bars/t4—6 months after 3^rd ADRC application, P3—respond patient number 3, P6—mild responder, P4—nonresponder.